DekaBank Deutsche Girozentrale Share Price

Certificat

DE000DK0SKJ4

Market Closed - Deutsche Boerse AG 16:00:19 31/05/2024 BST
1,155 EUR +0.51% Intraday chart for DekaBank Deutsche Girozentrale
Current month+5.18%
1 month+5.18%
Date Price Change
31/05/24 1,155 +0.51%
30/05/24 1,149 +0.38%
29/05/24 1,145 -0.57%
28/05/24 1,151 +0.03%
27/05/24 1,151 +1.07%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 04:00 pm

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
Issuer Deka
WKN DK0SKJ
ISINDE000DK0SKJ4
Date issued 28/01/2019
Strike 45.11
Maturity 21/03/2025 (293 Days)
Parity 0.05 : 1
Emission price 1,000
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1,155
Lowest since issue 638.7
Spread 10
Spread %0.86%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.28 EUR
Average target price
36.72 EUR
Spread / Average Target
+25.43%
Consensus